Simultaneous influenza and pneumococcal vaccination in elderly individuals

Area of Science:

• Immunology
• Vaccinology
• Geriatrics

Background:

• Elderly individuals are at higher risk for severe outcomes from influenza and pneumococcal infections.
• Vaccination is a key strategy for preventing these diseases in older adults.
• The efficacy and safety of co-administering influenza and pneumococcal vaccines require evaluation.

Purpose of the Study:

• To assess the effects of administering influenza and pneumococcal vaccines alone or in combination.
• To evaluate the safety and immunogenicity of simultaneous vaccination in elderly subjects.

Main Methods:

• 124 community-dwelling elderly subjects received either influenza split vaccine, pneumococcal 23-valent vaccine, or both vaccines concurrently at different sites.
• Sera were analyzed for hemagglutination inhibiting antibodies against influenza and antibodies against Streptococcus pneumoniae.
• No adverse events were reported in the vaccinated population.

Main Results:

• Influenza vaccination significantly increased antibody levels.
• No significant differences in GMT, protected individuals, or seroconversion rates were observed between groups receiving influenza vaccine alone versus in combination with pneumococcal vaccine.
• A non-statistically significant reduction in mean antibody concentration and mean fold increase was noted when pneumococcal vaccine was co-administered with influenza vaccine.

Conclusions:

• Simultaneous administration of influenza and pneumococcal vaccines is safe for elderly individuals, including those at high risk.
• Co-administration is effective, demonstrating comparable immunogenicity to individual vaccinations.
• Concurrent vaccination offers potential economic advantages.